Scarica l'app Stockscreener
111.42
1.28%
-1.44
Dopo l'orario di chiusura:
113.59
2.17
+1.95%
Inhibrx Biosciences Inc Azioni (INBX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-07-01 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | 0.10 | - |
Operating Expenses
|
33.81
|
- | 42.90 | 50.03 | 46.80 |
| Operating Income/Loss |
-33.81
|
- | -42.90 | -49.93 | -46.80 |
| Nonoperating Income/Loss |
-1.444
|
- | -0.41 | 2.063 | 2.933 |
| Income/Loss From Continuing Operations Before Tax |
23.04%
-35.26
|
-28.65 | -43.31 | -47.87 | -43.86 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
23.04%
-35.26
|
-28.65 | -43.31 | -47.87 | -43.86 |
|
Net Income/Loss
|
23.04%
-35.26
|
-28.65 | -43.31 | -47.87 | -43.86 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
15.48
|
- | 15.47 | 0.224 | 15.47 |
| Diluted Average Shares |
15.48
|
- | 15.47 | 0.163 | 15.47 |
| Basic Earnings Per Share |
-2.28
|
- | -2.80 | -5.03 | -2.84 |
| Diluted Earnings Per Share |
-2.28
|
- | -2.80 | -4.47 | -2.84 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):